[Bis(3,5‐diisopropylpyrazol‐1‐yl‐κ N 2 )dihydroborato](triphenylphosphane‐κ P )copper(I)

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/102235/1/S0108270113015965.pd

Crystal structure and spectroscopic properties of chlorido{hydridotris[3-,5-dimethylpyrazol-1-yl-κN3]borato}(3-,5-dimethylpyrazol-1-yl-κN)copper(II), C20H30BClCuN8

C20H30BClCuN8, monoclinic, P21/c (no. 14), a = 17.1345(7) Å, b = 7.8207(2) Å, c = 19.0213(8) Å, β = 108.268(1)°, V = 2420.46(16) Å3, Z = 4, Rgt(F) = 0.0322, wRref(F2) = 0.0876, T = 184 K

Redetermination of the crystal structure of bis{hydridotris(3,5-dimethylpyrazol-1-yl-κN3)borato} copper(II), C30H44B2CuN12

C30H44B2CuN12, triclinic, P1 (no. 2), a = 8.6801(1) Å, b = 10.1688(2) Å, c = 10.7290(2) Å, α = 62.672(2)°, β = 84.3550(10)°, γ = 78.9700(10)°, V = 825.71(3) Å3 , Z = 1,Rgt(F) = 0.0318, wRref(F2) = 0.0961, T = 178 K

Crystal structure of chlorido{hydridotris[3-phenyl-5-methylpyrazol-1-yl-κN3]borato}copper(II), C30H28BClCuN6

C30H28BClCuN6, triclinic, P¯1 (no. 2), a = 11.549(3) Å, b = 12.321(3) Å, c = 12.348(4) Å, α = 111.785(1)°, β = 116.664(3)°, γ = 97.513(1)°, V = 1361.3(7) Å3, Z = 2, Rgt(F) = 0.0440, wRref(F2) = 0.1063, T = 197 K

Crystal structure of carbonyl{hydridotris[3-phenyl-5-methylpyrazol-1-yl]borato-κ3N,N′N′′}copper(I), C31H28BCuN6O

C31H28BCuN6O, monoclinic, P21/n (no. 14), a = 11.506(3) Å, b = 16.122(3) Å, c = 15.805(3) Å, β = 99.433(3)°, V = 2892.2(11) Å3, Z = 4, Rgt(F) = 0.0501, wRref(F2) = 0.1260, T = 193(2) K

Crystal structure of bis{hydridotris(3-trifluoromethyl-5-methylpyrazolyl-1-yl)borato-κN 3}manganese(II), C30H26B2F18MnN12

C30H26B2F18MnN12, triclinic, P1 (no. 2), a = 10.5322(3) Å, b = 10.6475(4) Å, c = 10.9890(4) Å, α = 111.755(3)°, β = 99.100(2)°, γ = 112.740(3)°, V = 988.07(7) Å3, Z = 1, Rgt(F) = 0.0338, wRref(F2) = 0.0907, T = 178 K

Structural and Hirshfeld surface analysis of thallium(I) and indium(III) complexes of a soft scorpionate ligand

Two complexes containing a soft sulfur-substituted tris(pyrazolyl)hydroborate ligand, namely [TlI(TmtBu)]2∙2H2O and [InIII(TmtBu)2](InCl4), where TmtBu is the tris(3-tert-butyl-2-sulfanylidene-1H-imidazol-1-yl)hydroborate anion, have been characterized. The {TlS}2 core of the former has the shape of a diamond. Each S atom of the TmtBu anion coordinates differently: one S is connected to one Tl atom, one bridges both Tl atoms, while the third S atom connects solely to the second Tl atom. The S4 donor set defines a seesaw geometry. The independent H2O molecule forms O–H···S and localized O–H···π(pyrazolyl) contacts. Flattened octahedral geometries defined by S6 donor sets are noted for the two independent cations in [InIII(TmtBu)2](InCl4). In the crystal of [TlI(TmtBu)]2∙2H2O, pyrazolyl-C–H···O(water) interactions connect the dimeric units into a linear supramolecular chain, chains pack without directional interactions between them. In the crystal of [InIII(TmtBu)2](InCl4), alternating rows of independent cations are interspersed by anions. The primary points of contact within a three-dimensional architecture are of the type In–Cl···π(pyrazolyl) and C–H···Cl. The assessment of the molecular packing was complemented by considering the calculated Hirshfeld surfaces and two-dimensional fingerprint plots (overall and delineated into individual contacts)

Transcriptional Repression of Cdc25B by IER5 Inhibits the Proliferation of Leukemic Progenitor Cells through NF-YB and p300 in Acute Myeloid Leukemia

The immediately-early response gene 5 (IER5) has been reported to be induced by γ-ray irradiation and to play a role in the induction of cell death caused by radiation. We previously identified IER5 as one of the 2,3,4-tribromo-3-methyl-1-phenylphospholane 1-oxide (TMPP)-induced transcriptional responses in AML cells, using microarrays that encompassed the entire human genome. However, the biochemical pathway and mechanisms of IER5 function in regulation of the cell cycle remain unclear. In this study, we investigated the involvement of IER5 in the cell cycle and in cell proliferation of acute myeloid leukemia (AML) cells. We found that the over-expression of IER5 in AML cell lines and in AML-derived ALDHhi (High Aldehyde Dehydrogenase activity)/CD34+ cells inhibited their proliferation compared to control cells, through induction of G2/M cell cycle arrest and a decrease in Cdc25B expression. Moreover, the over-expression of IER5 reduced colony formation of AML-derived ALDHhi/CD34+ cells due to a decrease in Cdc25B expression. In addition, over-expression of Cdc25B restored TMPP inhibitory effects on colony formation in IER5-suppressed AML-derived ALDHhi/CD34+ cells. Furthermore, the IER5 reduced Cdc25B mRNA expression through direct binding to Cdc25B promoter and mediated its transcriptional attenuation through NF-YB and p300 transcriptinal factors. In summary, we found that transcriptional repression mediated by IER5 regulates Cdc25B expression levels via the release of NF-YB and p300 in AML-derived ALDHhi/CD34+ cells, resulting in inhibition of AML progenitor cell proliferation through modulation of cell cycle. Thus, the induction of IER5 expression represents an attractive target for AML therapy

Clinical application of removable partial dentures using thermoplastic resin—Part I: Definition and indication of non-metal clasp dentures

AbstractThis position paper proposes a definition and naming standard for removable partial dentures (RPDs) using thermoplastic resin, and presents a guideline for clinical application. A panel of 14 experts having broad experience with clinical application of RPDs using thermoplastic resin was selected from members of the Japan Prosthodontic Society. At a meeting of the panel, “non-metal clasp denture” was referred as the generic name of RPDs with retentive elements (resin clasps) made of thermoplastic resin. The panel classified non-metal clasp dentures into two types: one with a flexible structure that lacks a metal framework and the other having a rigid structure that includes a metal framework. According to current prosthetic principles, flexible non-metal clasp dentures are not recommended as definitive dentures, except for limited cases such as patients with a metal allergy. Rigid non-metal clasp dentures are recommended in cases where patients will not accept metal clasps for esthetic reasons. Non-metal clasp dentures should follow the same design principles as conventional RPDs using metal clasps

Japan Prosthodontic Society position paper on “occlusal discomfort syndrome”

Purpose: Dentists may encounter patients who present with a sense of a malocclusion but in whom no objective findings can be detected. For the patient who insists that there is occlusal discomfort, in the absence of evidence some dentists elect to perform an occlusal adjustment that not only fails to alleviate symptoms, and may, in fact, exacerbate the discomfort. The patient–dentist relationship is then likely compromised because of a lack of trust. Study selection: In 2011, the Clinical Practice Guidelines Committee of the Japan Prosthodontic Society formulated guidelines for the management of occlusal discomfort. When formulating clinical practice guidelines, the committee bases their recommendations on information derived from scientific evidence. For ‘‘occlusal dysesthesia,’’ however, there are an insufficient number of high-quality papers related to the subject. Therefore, a consensus meeting was convened by the Japan Prosthodontic Society to examine evidence in the Japanese- and English-language literature and generate a multi-center survey to create an appropriate appellation for this condition. Results: As a result of the consensus meeting and survey findings, this condition may be justifiably termed ‘‘occlusal discomfort syndrome.’’ Conclusions: The Japan Prosthodontics Society believes that identification of an umbrella term for occlusal discomfort might serve as a useful guide to formulating clinical practice guidelines in the future. This position paper represents summary findings in the literature combined with the results of a multicenter survey focused on dental occlusal treatment and the condition of patients who present with occlusal discomfort syndrome